FERRARI, CAMILLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 5.429
NA - Nord America 4.890
EU - Europa 3.034
SA - Sud America 291
AF - Africa 46
OC - Oceania 43
Continente sconosciuto - Info sul continente non disponibili 1
Totale 13.734
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.838
HK - Hong Kong 2.620
RU - Federazione Russa 1.520
SG - Singapore 1.044
CN - Cina 976
KR - Corea 367
IT - Italia 307
IE - Irlanda 276
PL - Polonia 266
BR - Brasile 236
SE - Svezia 188
DE - Germania 168
IN - India 126
FI - Finlandia 107
VN - Vietnam 85
GB - Regno Unito 60
ID - Indonesia 59
JO - Giordania 50
AU - Australia 43
AR - Argentina 27
FR - Francia 27
AT - Austria 25
CA - Canada 23
NL - Olanda 21
MX - Messico 20
ES - Italia 17
JP - Giappone 16
BD - Bangladesh 15
ZA - Sudafrica 13
BJ - Benin 12
IQ - Iraq 12
UA - Ucraina 12
TR - Turchia 11
BE - Belgio 8
PK - Pakistan 8
CH - Svizzera 7
KZ - Kazakistan 7
MA - Marocco 7
EC - Ecuador 6
CI - Costa d'Avorio 5
CO - Colombia 5
CZ - Repubblica Ceca 5
PY - Paraguay 5
SA - Arabia Saudita 5
TW - Taiwan 5
VE - Venezuela 4
AE - Emirati Arabi Uniti 3
AZ - Azerbaigian 3
CL - Cile 3
GR - Grecia 3
KE - Kenya 3
PA - Panama 3
PH - Filippine 3
RS - Serbia 3
UZ - Uzbekistan 3
BG - Bulgaria 2
CR - Costa Rica 2
DK - Danimarca 2
DZ - Algeria 2
HU - Ungheria 2
IL - Israele 2
JM - Giamaica 2
KG - Kirghizistan 2
LT - Lituania 2
NP - Nepal 2
PE - Perù 2
PT - Portogallo 2
UY - Uruguay 2
BA - Bosnia-Erzegovina 1
DO - Repubblica Dominicana 1
EG - Egitto 1
ET - Etiopia 1
GY - Guiana 1
IR - Iran 1
IS - Islanda 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LK - Sri Lanka 1
LV - Lettonia 1
MK - Macedonia 1
NG - Nigeria 1
NI - Nicaragua 1
PS - Palestinian Territory 1
SN - Senegal 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 13.734
Salva come PNG Salva come JPEG
Città #
Hong Kong 2.555
Santa Clara 1.313
Singapore 788
Ashburn 713
Dallas 473
Hefei 397
Seoul 367
Dublin 275
Warsaw 264
Fairfield 228
Chandler 217
Beijing 128
Woodbridge 122
Houston 103
Seattle 100
Cambridge 85
Los Angeles 82
Moscow 82
Altamura 81
Lawrence 79
Buffalo 76
Munich 76
Florence 69
Wilmington 68
Mumbai 62
Ann Arbor 58
Kent 54
Jakarta 53
New York 48
Princeton 46
Dearborn 43
Helsinki 43
Melbourne 43
The Dalles 40
Boston 38
Ho Chi Minh City 34
Bremen 33
Lappeenranta 32
Shanghai 32
Turku 28
San Diego 26
São Paulo 23
Bengaluru 22
Pune 21
Medford 18
Nuremberg 17
Rome 17
West Jordan 16
Atlanta 15
Chicago 15
Paris 15
Stockholm 15
Boardman 13
Clifton 13
Hanoi 13
Cotonou 12
Frankfurt am Main 12
San Francisco 12
Montreal 11
Vienna 11
Ferrara 10
Tokyo 10
Brooklyn 9
Denver 9
Orem 9
Brussels 8
Falkenstein 8
Toronto 8
Belo Horizonte 7
Chennai 7
Guangzhou 7
London 7
Phoenix 7
Poplar 7
Yubileyny 7
Dong Ket 6
Falls Church 6
Johannesburg 6
Lambeth 6
Manchester 6
Norwalk 6
Querétaro 6
Redondo Beach 6
Rio de Janeiro 6
Abidjan 5
Amsterdam 5
Barcelona 5
Dhaka 5
Haiphong 5
Mexico City 5
Milan 5
Misano Adriatico 5
New Delhi 5
Prato 5
Ribeirão Preto 5
Romola 5
Zhengzhou 5
Ankara 4
Baghdad 4
Basra 4
Totale 9.996
Salva come PNG Salva come JPEG
Nome #
Behavioural disorders in Alzheimer's disease: the descriptive and predictive role of brain 18F-fluorodesoxyglucose-positron emission tomography 2.259
Clinical and neuroimaging profiles to identify C9orf72-FTD patients and serum Neurofilament to monitor the progression and the severity of the disease 358
Low Florbetapir PET Uptake and Normal Aβ1-42 Cerebrospinal Fluid in an APP Ala713Thr Mutation Carrier 303
"Delirium Day": A nationwide point prevalence study of delirium in older hospitalized patients using an easy standardized diagnostic tool 285
Alzheimer's Disease Progression: Factors Influencing Cognitive Decline 206
Age at symptom onset and death and disease duration in genetic frontotemporal dementia: an international retrospective cohort study 186
Challenges in Alzheimer's Disease Diagnostic Work-Up: Amyloid Biomarker Incongruences 183
Apathy in presymptomatic genetic frontotemporal dementia predicts cognitive decline and is driven by structural brain changes 181
Potential genetic modifiers of disease risk and age at onset in patients with frontotemporal lobar degeneration and GRN mutations: a genome-wide association study 176
Anomia is present pre-symptomatically in frontotemporal dementia due to MAPT mutations 174
Biomarkers study in atypical dementia: proof of a diagnostic work-up 172
Cognitive functioning among patients with diabetic foot 171
Brain functional network integrity sustains cognitive function despite atrophy in presymptomatic genetic frontotemporal dementia 171
The Games for Older Adults Active Life (GOAL) project for people with mild cognitive impairment and vascular cognitive impairment: A study protocol for a randomized controlled trial 171
Dual Effect of PER2 C111G Polymorphism on Cognitive Functions across Progression from Subjective Cognitive Decline to Mild Cognitive Impairment 167
CAG Repeats Within the Non-pathological Range in the HTT Gene Influence Personality Traits in Patients With Subjective Cognitive Decline: A 13-Year Follow-Up Study 166
Primary Progressive Aphasia: Natural History in an Italian Cohort 164
Alzheimer's Disease CSF Biomarker Profiles in Idiopathic Normal Pressure Hydrocephalus 162
Loss of speech and functional impairment in Alzheimer's disease-related primary progressive aphasia: predictive factors of decline 157
High Frequency of Crossed Aphasia in Dextral in an Italian Cohort of Patients with Logopenic Primary Progressive Aphasia 157
Italian Frontotemporal Dementia Network (FTD Group-SINDEM): sharing clinical and diagnostic procedures in Frontotemporal Dementia in Italy 157
FDG PET in the differential diagnosis of degenerative parkinsonian disorders: usefulness of voxel-based analysis in clinical practice 154
Data-driven staging of genetic frontotemporal dementia using multi-modal MRI 153
Analysis of brain atrophy and local gene expression in genetic frontotemporal dementia 150
Cognitive composites for genetic frontotemporal dementia: GENFI-Cog 150
Functional network resilience to pathology in presymptomatic genetic frontotemporal dementia 149
Influence of apoe genotype and clock t3111c interaction with cardiovascular risk factors on the progression to alzheimer’s disease in subjective cognitive decline and mild cognitive impairment patients 148
Cerebrospinal fluid biomarkers for dementia: A case of post-lumbar puncture epidural hematoma 148
Intermediate alleles of HTT: A new pathway in longevity 147
The Frequency of Intermediate Alleles in Patients with Cerebellar Phenotypes 147
Imaging and Cognitive Reserve Studies Predict Dementia in Presymptomatic Alzheimer's Disease Subjects. 147
Temporal order of clinical and biomarker changes in familial frontotemporal dementia 146
Motor and cognitive outcomes of cerebello-spinal stimulation in neurodegenerative ataxia 143
Huntingtin gene intermediate alleles influence the progression from subjective cognitive decline to mild cognitive impairment: A 14-year follow-up study 143
Linguistic profiles, brain metabolic patterns and rates of amyloid-β biomarker positivity in patients with mixed primary progressive aphasia 143
Drug prescription and delirium in older inpatients: Results from the nationwide multicenter Italian Delirium Day 2015-2016 139
Plasma neurofilament light chain as a biomarker of Alzheimer's disease in Subjective Cognitive Decline and Mild Cognitive Impairment 138
Long-term use of pharmacological treatment in Alzheimer's disease: a retrospective cohort study in real-world clinical practice 137
Parkinson-ALS with a novel MAPT variant 135
Conceptual framework for the definition of preclinical and prodromal frontotemporal dementia 134
Neurofilament Light Chain and Intermediate HTT Alleles as Combined Biomarkers in Italian ALS Patients 134
Rethinking on the concept of biomarkers in preclinical Alzheimer’s disease 131
The diagnosis of dementias: a practical tool not to miss rare causes 131
Impairment of episodic memory in genetic frontotemporal dementia: A genfi study 128
Loss of brainstem white matter predicts onset and motor neuron symptoms in C9orf72 expansion carriers: a GENFI study 125
GRN Missense Variants and Familial Alzheimer’s Disease: Two Case Reports 125
Cerebellar and subcortical atrophy contribute to psychiatric symptoms in frontotemporal dementia 125
The complexity of Alzheimer's disease: an evolving puzzle 124
The Huntington’s Disease Gene in an Italian Cohort of Patients with Bipolar Disorder 122
Motor symptoms in genetic frontotemporal dementia: developing a new module for clinical rating scales 120
Future perspective and clinical applicability of the combined use of plasma phosphorylated tau 181 and neurofilament light chain in Subjective Cognitive Decline and Mild Cognitive Impairment 118
The novel PSEN1 M84V mutation associated to frontal dysexecutive syndrome, spastic paraparesis, and cerebellar atrophy in a dominant Alzheimer's disease family 116
Examining empathy deficits across familial forms of frontotemporal dementia within the GENFI cohort 114
Development of a sensitive trial-ready poly(GP) CSF biomarker assay for C9orf72-associated frontotemporal dementia and amyotrophic lateral sclerosis 114
A data-driven disease progression model of fluid biomarkers in genetic frontotemporal dementia 114
Novel GRN Mutations in Alzheimer's Disease and Frontotemporal Lobar Degeneration 114
Gender differences in cognitive reserve: implication for subjective cognitive decline in women 114
A panel of CSF proteins separates genetic frontotemporal dementia from presymptomatic mutation carriers: a GENFI study 113
Progression of Behavioral Disturbances and Neuropsychiatric Symptoms in Patients With Genetic Frontotemporal Dementia 107
Differential early subcortical involvement in genetic FTD within the GENFI cohort 107
Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores 103
The effect of cag repeats within the non-pathological range in the htt gene on cognitive functions in patients with subjective cognitive decline and mild cognitive impairment 102
Comparing Cerebellar tDCS and Cerebellar tACS in Neurodegenerative Ataxias Using Wearable Sensors: A Randomized, Double-Blind, Sham-Controlled, Triple-Crossover Trial 102
No supportive evidence for TIA1 gene mutations in a European cohort of ALS-FTD spectrum patients 101
The CBI-R detects early behavioural impairment in genetic frontotemporal dementia 100
Comparison of clinical rating scales in genetic frontotemporal dementia within the GENFI cohort 100
Plasma glial fibrillary acidic protein is raised in progranulin-associated frontotemporal dementia 99
Late-onset Huntington disease: An Italian cohort 99
Diagnostic accuracy of research criteria for prodromal frontotemporal dementia 98
Plasma GFAP, NfL and pTau 181 detect preclinical stages of dementia 96
Structural brain splitting is a hallmark of Granulin-related Frontotemporal Dementia 93
Long Non-Coding RNA Profile in Genetic Symptomatic and Presymptomatic Frontotemporal Dementia: A GENFI Study 91
The Revised Self-Monitoring Scale detects early impairment of social cognition in genetic frontotemporal dementia within the GENFI cohort 89
Network structure and transcriptomic vulnerability shape atrophy in frontotemporal dementia 88
Practice effects in genetic frontotemporal dementia and at-risk individuals: a GENFI study 87
Language impairment in the genetic forms of behavioural variant frontotemporal dementia 85
MRI data-driven algorithm for the diagnosis of behavioural variant frontotemporal dementia 83
Stratifying the Presymptomatic Phase of Genetic Frontotemporal Dementia by Serum NfL and pNfH: A Longitudinal Multicentre Study 82
Longitudinal cerebral perfusion in presymptomatic genetic frontotemporal dementia: GENFI results 81
How can elderly apolipoprotein E ε4 carriers remain free from dementia? 80
Incomplete penetrance in familial Alzheimer’s disease with PSEN1 Ala260Gly mutation 78
CSF glial markers are elevated in a subset of patients with genetic frontotemporal dementia 77
Impaired glymphatic system in genetic frontotemporal dementia: a GENFI study 72
Prodromal language impairment in genetic frontotemporal dementia within the GENFI cohort 69
Structural MRI predicts clinical progression in presymptomatic genetic frontotemporal dementia: findings from the GENetic Frontotemporal dementia Initiative cohort 69
NfL reliability across laboratories, stage-dependent diagnostic performance and matrix comparability in genetic FTD: a large GENFI study 66
Differential impairment of cerebrospinal fluid synaptic biomarkers in the genetic forms of frontotemporal dementia 65
Matching clinical diagnosis and amyloid biomarkers in alzheimer’s disease and frontotemporal dementia 63
null 63
Temporal dynamics predict symptom onset and cognitive decline in familial frontotemporal dementia 59
Genome-wide analyses reveal a potential role for the MAPT, MOBP, and APOE loci in sporadic frontotemporal dementia 22
Totale 13.835
Salva come PNG Salva come JPEG
Categoria #
all - tutte 39.931
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 39.931
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021216 0 0 0 0 0 14 13 22 50 73 17 27
2021/2022315 6 7 17 12 4 24 1 42 13 20 66 103
2022/20231.161 102 233 73 93 66 205 165 56 125 6 23 14
2023/2024910 30 50 76 32 39 84 57 406 23 56 37 20
2024/20254.311 119 434 276 640 1.143 563 61 276 158 135 206 300
2025/20265.982 649 2.899 1.106 477 807 44 0 0 0 0 0 0
Totale 13.835